NCT05121181 is a clinical trial of delphi project in Cholelithiasis, sponsored by Candido Fernando Alcazar-Lopez.

Who is sponsoring NCT05121181?

NCT05121181 is sponsored by Candido Fernando Alcazar-Lopez.

What drugs are being tested in NCT05121181?

Interventions in NCT05121181: delphi project.

What condition does NCT05121181 study?

NCT05121181 studies Cholelithiasis.

Is NCT05121181 still recruiting?

NCT05121181 is currently completed. Last updated 16 November 2021.

Last reviewed 2021-11-16 · How we verify

NCT05121181

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reaching Consensus on the Definition of Difficult Cholecystectomy

Completed Last updated 16 November 2021

What this trial tests

trial testing delphi project in Cholelithiasis in 46 participants. Completed in 1 January 2021.

Timeline

1 July 2020

Primary endpoint
15 November 2020

1 January 2021

Quick facts

Lead sponsor	Candido Fernando Alcazar-Lopez
Status	Completed
Study type	OBSERVATIONAL
Enrollment	46
Start date	1 July 2020
Primary completion	15 November 2020
Estimated completion	1 January 2021
Sites	1 location across Spain

Drugs / interventions tested

delphi project

Conditions studied

Cholelithiasis — all drugs for Cholelithiasis →

Sponsor

Candido Fernando Alcazar-Lopez

Who can join

Eligibility, any sex, with Cholelithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Being able to predict the difficulty of a preoperatively can increase safety and improve results. However, a consensus must be reached regarding the definition of a cholecystectomy as "difficult". The aim of this study is to achieve a national expert consensus. Methods A Delphi study was conducted. Based on the literature, a history of biliary pathology, preoperative clinical, analytical, and radiological data, and intraoperative findings were selected and rated on a Likert scale. Inter-rater agreement was defined as "unanimous" when 100% of the participants gave an item the same the Likert scale rating; as "consensus" when ≥80% agreed; as "majority" when the agreement was ≥70%.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT07308730 — Pain Diary Use After Laparoscopic Cholecystectomy · NA · recruiting
NCT07001423 — ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly · NA · recruiting
NCT07051980 — Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two · Phase 2 · recruiting
NCT07012772 — COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05121181 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Candido Fernando Alcazar-Lopez
Last refreshed: 16 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05121181.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing